The OHDSI community has reached an important milestone!
We are excited to announce that Project CHARYBDIS has successfully been tested on multiple databases. We are actively seeking data partners to run CHARYBDIS on their networks. While we are building documentation on this study, any data partners should feel free to reach out to our CHARYBDIS leads (Kristin Kostka, Talita Duarte-Salles and Albert Prats-Uribe) for added assistance.
The protocol and study code is available here: https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis.
As a reminder, Project CHARYBDIS stands for Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2. There are two main objectives for CHARYBDIS: 1) Describe the baseline demographic, clinical characteristics, treatments and outcomes of interest among individuals tested for SARS-CoV-2 and/or diagnosed with COVID-19 overall and stratified by sex, age and specific comorbidities; 2) Describe characteristics and outcomes of hospitalized influenza patients between September 2017 and April 2018 compared to the COVID-19 population.
There are numerous study topics that can be focused within this project, including asthma, cancer, cardiac outcomes, chronic kidney disease, COPD, elderly, end-stage renal disease, gender differences, heart disease, hepatitis C, HIV infection, hypertension, immune disorders, obesity, pediatrics, pregnancy, testing, tuberculosis, type 2 diabetes, and plenty more.